prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |review
Several strategies are available. One should be best for your local situation. This is just an example for South America. As a complementary measure test the immunologic situation of: 1)all pregnant women, and vaccinate the seronegative ones during puerperium. 2)reproductive age women of risk groups (physicians, nurses, teachers), and vaccinate the seronegative ones or just vaccinate all women in the risk group.

Cutts FT, Robertson SE, Diaz-Ortega JL, Samuel R (1997) Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS. Bull World Health Organ 75:55-68.
Robertson SE, Cutts FT, Samuel R, Diaz-Ortega JL. (1997) Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella. Bull World Health Organ 75:69-80.